Page 82 - 南京医科大学自然版
P. 82

南京医科大学学报(自然科学版)                                  第44卷第7期
               ·966 ·                     Journal of Nanjing Medical University(Natural Sciences)   2024年7月


             ·临床研究·

              体外开窗技术治疗主动脉弓部病变的中期效果



              李 钢,徐心阳,刘 鸿,李明辉,顾嘉玺,倪布清                      *
              南京医科大学第一附属医院心脏大血管外科,江苏                   南京   210029




             [摘 要] 目的:探究胸主动脉腔内修复术(thoracic endovascular aortic repair,TEVAR)联合左锁骨下动脉(left subclavian artery,
              LSA)体外开窗技术治疗主动脉弓部病变的中期效果。方法:选择2018年1月—2021年12月南京医科大学第一附属医院收治
              的111例行TEVAR联合LSA体外开窗技术治疗的患者,回顾性分析其围术期以及中期随访的临床材料。结果:手术成功率为
              100%(111/111),30 d内病死率为3.6%(4/111),术后中位随访时间为33.0个月,全因病死率为6.3%(7/111),主动脉相关的病死
              率为2.7%(3/111),主要并发症中脑血管意外3例(2.7%),截瘫2例(1.8%),近端逆撕形成A型主动脉夹层1例(0.9%),支架内
              漏 2 例(1.8%),支架移植物引起远端新发破口 3 例(2.7%)。进行主动脉二次干预的有 4 例(3.6%),其中 3 例(2.7%)腔内手
              术,1 例(0.9%)开胸行人工血管置换手术。结论:TEVAR联合LSA体外开窗技术治疗主动脉弓部病变的中期效果在可接受的
              范围内,但是仍缺乏长期的观察结果数据。此外,开窗技术流程亟待规范统一,相关设备也待进一步开发。
             [关键词] 主动脉夹层;主动脉腔内修复术;体外开窗技术;左锁骨下动脉;支架内移植物
             [中图分类号] R654.3                    [文献标志码] A                      [文章编号] 1007⁃4368(2024)07⁃966⁃06
              doi:10.7655/NYDXBNSN240127



              Midterm outcomes of surgeon⁃modified fenestrated stent⁃graft for aortic arch pathologies
              LI Gang,XU Xinyang,LIU Hong,LI Minghui,GU Jiaxi,NI Buqing *
              Department of Cardiac Surgery,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China


             [Abstract] Objective:To investigate the midterm outcomes of thoracic endovascular aortic repair(TEVAR)combined with left
              subclavian artery(LSA)fenestration for aortic arch diseases. Methods:We retrospectively analyzed the perioperative period and
              midterm follow⁃up clinical data of 111 patients who underwent TEVAR combined with LSA fenestration in the First Affiliated Hospital
              of Nanjing Medical University from January 2018 to December 2021. Results:Overall,the success rate of the surgery was 100%(111/
              111),the mortality rate within 30 days was 3.6%(4/111). The median postoperative follow⁃up time was 33.0 months,the all⁃cause
              mortality was 6.3%(7/111),the aorta⁃related mortality was 2.7%(3/111). Among the main complications,there were 3 patients(2.7%)
              of cerebrovascular accident,2 patients(1.8%)of paraplegia,1 patient(0.9%)of retrograde type A dissection(RTAD),2 patients
             (1.8%)of endoleak,and 3 patients(2.7%)of distal stent⁃induced new entry(dSINE). Four patients(3.6%)underwent the second
              aortic intervention,of which 3 patients(2.7%)were performed endovascular surgery and 1 patient(0.9%)was performed thoracotomy
              and artificial vascular replacement. Conclusion:The mid⁃term outcomes of TEVAR combined with LSA fenestration for aortic arch
              diseases were within the acceptable range,however,further follow⁃up results are needed and long⁃term stability and durability needs to
              be assessed. In addition,the technical process of fenestration needs to be standardized and unified,and related equipment needs to be
              further developed.
             [Key words] aortic dissection;thoracic endovascular aortic repair;in vitro fenestration;left subclavian artery;endovascular graft
                                                                            [J Nanjing Med Univ,2024,44(07):966⁃971]









             [基金项目] 南京医科大学专病联盟公益项目(NMU2023SD101)
              ∗
              通信作者(Corresponding author),E⁃mail:nibuqing@njmu.edu.cn
   77   78   79   80   81   82   83   84   85   86   87